Informed choice and decision making in women offered cell-free DNA prenatal genetic screening

2017 ◽  
Vol 37 (3) ◽  
pp. 299-302 ◽  
Author(s):  
Tsz-Kin Lo ◽  
Kelvin Yuen-Kwong Chan ◽  
Anita Sik-Yau Kan ◽  
Po-Lam So ◽  
Choi-Wah Kong ◽  
...  
Keyword(s):  
Decision Making ◽  
Genetic Screening ◽  
Informed Choice ◽  
Cell Free Dna ◽  
Free Dna

Molecular karyotyping of cell-free DNA from blastocoele fluid as a basis for noninvasive preimplantation genetic screening of aneuploidy

2015 ◽  
Vol 51 (11) ◽  
pp. 1123-1128 ◽  
Author(s):  
N. A. Skryabin ◽  
I. N. Lebedev ◽  
V. G. Artukhova ◽  
D. I. Zhigalina ◽  
I. A. Stepanov ◽  
...  
Keyword(s):  
Genetic Screening ◽  
Preimplantation Genetic Screening ◽  
Molecular Karyotyping ◽  
Cell Free Dna ◽  
Free Dna

scholarly journals Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening

2016 ◽  
Vol 19 (5) ◽  
pp. 559-567 ◽  
Author(s):  
Andrew P. Dervan ◽  
Patricia A. Deverka ◽  
Julia R. Trosman ◽  
Christine B. Weldon ◽  
Michael P. Douglas ◽  
...  
Keyword(s):  
Decision Making ◽  
Next Generation Sequencing ◽  
Prenatal Screening ◽  
Next Generation ◽  
Genetic Tests ◽  
Cell Free Dna ◽  
Free Dna ◽  
Generation Sequencing

Noninvasive Prenatal Genetic Screening Using Cell-free DNA

JAMA ◽  
2018 ◽  
Vol 320 (6) ◽  
pp. 591 ◽  
Author(s):  
Megan A. Allyse ◽  
Myra J. Wick
Keyword(s):  
Genetic Screening ◽  
Cell Free Dna ◽  
Free Dna

scholarly journals Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening

2017 ◽  
Vol 1 (19) ◽  
pp. 1491-1494 ◽  
Author(s):  
Marlise R. Luskin ◽  
Marie N. Discenza ◽  
Sarah Rae Easter ◽  
Paola Dal Cin ◽  
Renius Owen ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Genetic Screening ◽  
Chromosomal Abnormalities ◽  
Lymphoblastic Leukemia ◽  
Cell Free Dna ◽  
Fetal Aneuploidy ◽  
Free Dna ◽  
Key Points ◽  
Fetal Karyotype

Key Points cfDNA sequencing for fetal aneuploidy may detect chromosomal abnormalities representative of maternal malignancy. Maternal malignancy must be considered when abnormal cfDNA sequencing for fetal aneuploidy is associated with normal fetal karyotype.

Sign in / Sign up

Export Citation Format

Share Document